CPT® Code 64450

Quick Reference:

• What 64450 means: Injection of an anesthetic agent (and/or steroid) for a peripheral nerve or branch that is not specifically described by another more specific nerve-block CPT code. It is used for diagnostic or therapeutic nerve blockade (not for soft-tissue injections and not for routine surgical anesthesia).
• “Other peripheral nerve” is a catch-all: Use 64450 only when the nerve being blocked does not have a dedicated CPT nerve block code (e.g., when the nerve is not represented in 64400–64449 and other more specific families). If a more specific code describes the nerve/region, use the specific code instead.
• Medicare medical-necessity risk is diagnosis-driven: Medicare policy materials emphasize that diffuse/systemic neuropathies and non-nerve “tissue injections” are not appropriate rationales for 64450 coverage; documentation must support a focused, anatomically plausible nerve target and indication.
• Frequency limits matter: Medicare LCD guidance for peripheral nerve blocks includes utilization controls (e.g., more than three injections per anatomic site in six months may be denied, and more than two anatomic sites in a single session may be denied unless policy criteria and documentation support).
• Do not miscode Morton’s neuroma: Medicare coding guidance distinguishes nerve blocks for Morton’s neuroma and directs use of the specific code rather than using 64450 for that condition/service description.
• Bundling into surgery is a common denial trigger: National Correct Coding Initiative (NCCI) policy explains that local/regional anesthesia and many pre-/intra-operative services are part of the surgical package; do not report 64450 when it represents surgical anesthesia inherent to another procedure.
• Same-day E/M is not automatic: For minor procedures, NCCI policy describes how routine evaluation associated with the decision to perform the procedure is typically included; a separate E/M requires a genuinely significant, separately identifiable service supported by documentation (commonly with modifier 25 on the E/M when applicable).
• Ultrasound guidance can be separately reportable when criteria are met: ACEP reimbursement guidance discusses reporting of ultrasound guidance (e.g., 76942) with peripheral nerve blocks when performed and documented appropriately, subject to payer rules.

CPT 64450 is a high-risk “catch-all” nerve block code: it is clinically common, but it is also commonly denied or recouped when documentation does not clearly establish:

1. a specific nerve target,
2. a medically necessary indication aligned with payer coverage policy, and
3. that the service is not merely surgical anesthesia bundled into another procedure.

Medicare policy materials reinforce that peripheral nerve blocks are intended for focused, anatomically coherent services—not generalized neuropathy treatment or subcutaneous “tissue injections” billed as nerve blocks.

Clinical Definition and Proper Scope of CPT 64450

CPT 64450 describes an injection of anesthetic agent (and/or steroid) for an other peripheral nerve or branch. In coding terms, it functions as a nondestructive peripheral nerve block used for diagnostic or therapeutic purposes when the targeted nerve/branch is not described by a more specific CPT nerve-block code. The defining compliance principle is that 64450 is not a general “pain injection” code; it is a nerve block code and must be supported as such by the record.

• What the code represents: The administration service of placing medication at/near a named peripheral nerve or branch to block conduction for diagnostic or therapeutic effect.
• What it does not represent: Soft-tissue injections (e.g., tendon sheath, ligament, bursa), infiltrations into subcutaneous tissue without a nerve target, or anesthesia that is integral to another procedure. Medicare policy explicitly warns against treating subcutaneous injections or “tissue surrounding a focus” as 64450 services.

Practical boundary: If the record cannot clearly answer “Which nerve was blocked?” the claim is structurally vulnerable. Medicare policy materials emphasize that injections not involving the structures described by 64450 (i.e., not a true nerve block) should not be coded as 64450.

“Other peripheral nerve” means “no better code exists”

CPT uses a family of nerve-block codes for specific anatomic nerves/regions. 64450 is the residual category—appropriate only when a more specific nerve-block code does not describe the service. The defensible approach is to confirm that the targeted nerve is not already represented by a dedicated code and that the service is truly a peripheral nerve/branch block as documented.

When 64450 Is Appropriate (and When It Is Not)

flowchart TD
    A["Peripheral nerve injection performed"] --> B{"Is there a more specific\nCPT nerve block code\nfor this nerve?"}
    B -->|"Yes"| C["Use the specific code\ne.g. 64455 for Morton's neuroma"]
    B -->|"No"| D{"Is the injection targeting\na named peripheral nerve\nor branch?"}
    D -->|"No"| E["Do NOT use 64450\nConsider soft-tissue\ninjection codes"]
    D -->|"Yes"| F{"Was the block performed\nas anesthesia integral\nto another procedure?"}
    F -->|"Yes"| G["Do NOT report 64450\nseparately - bundled\ninto surgical package"]
    F -->|"No"| H{"Is the indication a\nfocal mononeuropathy\nor nerve-specific condition?"}
    H -->|"No - systemic neuropathy"| I["64450 likely non-covered\nby Medicare LCD"]
    H -->|"Yes"| J["Report 64450 with\ncomplete documentation"]
    J --> K{"Ultrasound guidance\nused and documented?"}
    K -->|"Yes"| L["Consider reporting\n76942 per payer rules"]
    K -->|"No"| M["64450 only"]

Common appropriate clinical contexts (coding intent)

In real-world practice, 64450 is often used for focused, peripheral mononeuropathic pain or focal neuralgia where an anatomically named peripheral nerve/branch is targeted and no more specific CPT code applies. Emergency medicine coding guidance commonly discusses peripheral nerve blocks (including upper-extremity nerve blocks) under 64450 when the nerve does not map to a more specific code, and it emphasizes correct bundling logic when performed as part of another service.

Medicare coverage policy for peripheral nerve blocks stresses that the service should be clinically reasonable and expected to resolve or substantially improve symptoms within a limited number of injections at the same site; repeated procedures without durable benefit raise coverage concerns.

Clear “do not use” boundaries

• Do not use 64450 for diffuse/systemic neuropathies: Medicare policy materials state that evidence is insufficient for peripheral nerve blocks in systemic neuropathies (for example, diabetic peripheral neuropathy) and treat such use as non-covered/investigational under LCD logic.
• Do not use 64450 for subcutaneous or soft-tissue injections: Medicare billing/coding guidance explains that subcutaneous injections and injections of tissue surrounding a focus (without direct nerve blockade) do not match the structure and intent of CPT 64450.
• Do not use 64450 when a specific code exists: Medicare coding guidance highlights situations (e.g., Morton’s neuroma-related injection contexts) where a more specific CPT code should be used rather than reporting 64450.
• Do not report 64450 as routine surgical anesthesia: NCCI policy explains bundling of anesthesia services into the surgical package; reporting 64450 as part of anesthesia inherent to another procedure is a classic denial/recoupment scenario.

Medicare Medical Necessity and Coverage Concepts

For Medicare, peripheral nerve block coverage is implemented through local coverage determinations (LCDs) and related billing/coding articles. These documents operationalize “reasonable and necessary” using (1) indications/limitations, (2) diagnosis code support logic, and (3) utilization controls. The core Medicare compliance concept is that 64450 must be justified as a targeted nerve block for a supported condition—not a generalized pain intervention.

Indication logic: focused nerve pathology vs generalized neuropathy

Medicare LCD guidance for peripheral nerve blocks emphasizes that the signs and symptoms supporting a block should resolve after one to three injections at a specific site, and it expresses skepticism (insufficient evidence) regarding use for neuropathies caused by underlying systemic diseases. This policy framing is important because it directly affects both initial claim payment and post-payment review.

Diagnosis-code alignment is not optional

Medicare’s billing/coding article for peripheral neuropathy nerve blocks includes explicit direction that certain therapies and injections are not to be coded with 64450, and it is commonly used by contractors to justify denials when claims appear to represent non-nerve injections or non-covered neuropathy treatment. In practical audits, the diagnosis on the claim must match the story in the note: a focal nerve problem with a plausible target and a reasonable therapeutic/diagnostic goal.

High-yield Medicare risk point: When the clinical note uses vague language (e.g., “neuropathy,” “pain,” “neuritis” without a specific nerve distribution and target), contractors may treat the service as non-covered or not meeting the structure of 64450. Medicare policy materials explicitly discuss inappropriate use when the injection does not involve the nerve structures described by the code.

Documentation Standards for Audit-Resistant Billing

Documentation must make the service independently auditable: a reviewer should be able to reconstruct what was done, why it was needed, and why 64450 (rather than another code) is correct. Medicare policy materials stress that documentation must support the billed service and that injections not matching the nerve-block structure should not be billed as 64450.

Minimum documentation elements (practical checklist)

• Named target nerve/branch: Identify the nerve explicitly (e.g., “ulnar nerve block at wrist,” “deep peroneal nerve block”), and document laterality.
• Clinical indication tied to anatomy: Describe symptoms and exam findings consistent with the nerve territory and diagnosis.
• Medication(s) and dose(s): Local anesthetic type, volume, concentration; steroid (if used) with dose; total volume injected.
• Technique and approach: Landmark-based vs ultrasound-guided; needle type; antisepsis; patient position; aspiration/negative blood return as clinically appropriate.
• Imaging guidance details (if used): If ultrasound guidance is billed, document that ultrasound was used and ensure the record supports separate reporting per payer rules; emergency medicine coding guidance discusses ultrasound guidance reporting in this context.
• Patient response/outcome: Immediate effect (e.g., pain reduction, sensory change) and adverse events.
• Rationale for repeat blocks: If repeating at the same site, document prior response and why repeat is reasonable within policy limits; Medicare LCD explicitly ties expected symptom resolution to a small number of injections.

Documentation that prevents “wrong code” denials

For services that resemble other injection categories (tendon sheath, ligament, Morton’s neuroma-related injections), Medicare coding guidance is commonly used to enforce code selection. The record should make it clear that this was a nerve block—not a tendon/ligament injection and not an injection scenario where a more specific nerve-related CPT code applies.

Modifiers, Imaging Guidance, and NCCI Bundling

Laterality and distinctness concepts

For unilateral services, payers commonly expect laterality (RT/LT) when relevant. For bilateral performance, coding often requires appropriate bilateral reporting conventions per payer rules. Because bilateral rules can vary by payer, the best defensibility strategy is to ensure the operative/procedure note clearly documents laterality and whether the blocks were performed as distinct services. (The core compliance focus remains documentation and policy alignment, rather than “modifier tactics.”)

Ultrasound guidance (when separately reportable)

If ultrasound guidance is used to perform a peripheral nerve block, reporting of ultrasound guidance (e.g., CPT 76942) may be appropriate when performed and documented according to payer requirements. ACEP reimbursement guidance discusses this billing concept for nerve blocks and highlights that bundling rules still apply when the block is part of another procedure.

NCCI bundling: surgical package and anesthesia services

The NCCI Policy Manual describes general correct coding principles and the concept of the medical/surgical package, including services that are considered integral to other procedures. In this framework, local/regional anesthesia and services performed as part of surgical anesthesia are typically not separately reportable. This is a central risk area for 64450 because peripheral nerve blocks are frequently performed to facilitate another procedure (e.g., laceration repair, incision and drainage, minor orthopedic procedures). When the block is merely the anesthesia component of the primary procedure, reporting 64450 is commonly non-compliant and will be denied or recouped.

Compliance principle (NCCI): Use 64450 as a separately reported service only when it is a distinct diagnostic/therapeutic nerve block service—not when it represents anesthesia inherent to another billed procedure.

Same-day E/M and modifier logic (minor procedure context)

NCCI policy regarding E/M services explains that for minor procedures, the typical pre-service evaluation and decision-making related to performing the procedure is generally included. A separate E/M on the same date must be supported as a significant, separately identifiable service beyond the usual work associated with the procedure. This is why routine “block-only” visits are often not defensible as separate E/M billing unless a distinct evaluation/management service is documented.

Medicare Utilization and Frequency Limits

Medicare LCD guidance for peripheral nerve blocks includes specific utilization controls designed to prevent repetitive injections without durable benefit. Key policy concepts include:

• Expected resolution within 1–3 injections at a site: LCD language indicates that signs and symptoms justifying a peripheral nerve block should be resolved after one to three injections at a specific site.
• More than three injections per anatomic site in six months may be denied: The LCD states that more than three injections per anatomic site in a six-month period will be denied.
• More than two anatomic sites in one session may be denied: The LCD states that injecting more than two anatomic sites at any one session will be denied.
• Systemic neuropathy treatment is disfavored: The LCD indicates insufficient evidence for peripheral nerve blocks in diabetic peripheral neuropathy and systemic-disease neuropathies, often leading to non-coverage in those contexts.

Operationally, practices should track injection history by specific nerve/branch and date to avoid inadvertent frequency violations, and they should document response trajectories (progressively sustained relief) when repeating blocks. The LCD explicitly advises exploring alternative therapeutic options if the patient does not achieve progressively sustained relief after two to three repeat injections on the same site.

Comparison Table: 64450 vs Common “Look-Alike” Codes

Real-World Clinical Scenarios

Scenario 1: ED peripheral nerve block for focal traumatic pain

Setting: Emergency Department

Service: Peripheral nerve block performed to provide focused analgesia for a focal injury, documented with named nerve target and laterality; ultrasound guidance used and documented.

Coding logic: 64450 may be appropriate if the block is a distinct therapeutic service and not merely anesthesia integral to another billable procedure. If ultrasound guidance is separately reportable and documented, guidance reporting may be considered subject to payer rules.

Documentation tip: Clearly document the nerve target, technique, medication and dose, patient response, and whether the block was performed as a separate therapeutic intervention versus anesthesia for a procedure.

Scenario 2: Clinic diagnostic block for focal mononeuropathy symptoms

Setting: Outpatient clinic

Service: Diagnostic peripheral nerve block of a named nerve/branch to confirm pain generator prior to longer-term management.

Coding logic: Align documentation to Medicare policy expectations: anatomically specific nerve target, plausible diagnosis and symptom pattern, and an appropriate treatment plan if relief is transient or absent.

Documentation tip: Record baseline symptoms, distribution, exam findings, and post-block response to support medical necessity and clinical reasoning.

Scenario 3: Attempted repeat blocks beyond utilization guidance

Setting: Outpatient pain management

Service: A patient receives repeated blocks of the same nerve/branch within a short timeframe with diminishing benefit.

Coding risk: Medicare LCD language states that more than three injections per anatomic site in a six-month period will be denied, and it expects progressively sustained relief after repeat injections; otherwise alternative options should be explored.

Defensive documentation: Track prior dates/response and document why any additional injection is clinically justified; if policy thresholds are exceeded, anticipate denial and consider ABN/coverage pathways as appropriate under Medicare rules.

Scenario 4: “Look-alike” injection coded as a nerve block

Setting: Podiatry/orthopedics clinic

Service: Injection performed for a foot pain condition that resembles a nerve block in lay terminology, but documentation indicates a different injection category or a more specific code pathway.

Coding logic: Medicare billing/coding guidance for injection services (including Morton’s neuroma-related contexts) is commonly used to enforce correct code selection and prevent miscoding as 64450 when the service matches another code pathway.

Documentation tip: Ensure the note states whether this is a true nerve block (named nerve target) versus soft-tissue injection; code accordingly.

Audit Triggers and Avoidable Billing Errors

• Vague target documentation (“nerve block performed” without naming the nerve): Medicare policy materials emphasize that injections not involving the nerve structures described by 64450 should not be coded as 64450; ambiguity invites denial.
• Billing 64450 as anesthesia integral to another procedure: NCCI policy explains bundling of anesthesia and related services into the surgical package; this is a common reason payers deny separate reporting.
• Misusing 64450 for systemic/diffuse neuropathy treatment: Medicare LCD language indicates insufficient evidence for peripheral nerve blocks in systemic neuropathies (including diabetic peripheral neuropathy), creating predictable non-coverage risk.
• Frequency violations: More than three injections per site in six months or more than two sites per session can trigger denials under LCD utilization controls.
• Wrong code selection for Morton’s neuroma-related services: Medicare coding guidance is explicit about correct injection coding pathways and is often used to correct/deny claims miscoded as 64450.
• Overstating same-day E/M: NCCI policy describes how routine evaluation for minor procedures is included; separate E/M requires distinct, documented work.
• Ultrasound guidance billed without support: If ultrasound guidance is reported, ensure the record supports it and that payer rules allow separate reporting; ACEP guidance discusses the general concept.